Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|12|3|162-170

ISSN： 1574-8863

Source： Current Drug Safety, Vol.12, Iss.3, 2017-10, pp. : 162-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tuberculosis screening prior to anti‐tumor necrosis factor therapy among patients with immune‐mediated inflammatory diseases in Japan: a longitudinal study using a large‐scale health insurance claims database

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 11, 2017-11 ,pp. : 1674-1683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial (Thematic Issue: The Biologics in Clinical Practice: A Modern Approach for Inflammatory and Immune-Mediated Diseases)

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 3-3

Bentham Science Publishers

Access to resources Recommend Favorite

Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1154-1160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002

By Robinson Don   Hackett Monica   Wong John   Kimball Alexa B.   Cohen Russell   Bala Mohan    

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 989-1000

Informa Healthcare

Access to resources Recommend Favorite

Acupuncture Reduces Immune-Mediated Pulmonary Inflammatory Lesions Induced in Rats

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 16, Iss. 6, 2009-12 ,pp. : 413-416

Karger

Access to resources Recommend Favorite